Quest Diagnostics Incorporated (LON:0KSX)

Market Cap	15.23B
Revenue (ttm)	8.07B
Net Income (ttm)	716.41M
Shares Out	n/a
EPS (ttm)	6.33
PE Ratio	21.26
Forward PE	17.45
Dividend	2.42 (1.34%)
Ex-Dividend Date	Oct 3, 2025

Volume	23
Average Volume	681
Open	181.12
Previous Close	182.22
Day's Range	180.54 - 182.38
52-Week Range	149.05 - 198.00
Beta	0.56
RSI	43.96
Earnings Date	Feb 2, 2026

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1967
• Employees: 56,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KSX

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD